Lancer Orthodontics Financials
| LANZ Stock | USD 0.01 0.00 0.00% |
Lancer |
Please note, the imprecision that can be found in Lancer Orthodontics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lancer Orthodontics. Check Lancer Orthodontics' Beneish M Score to see the likelihood of Lancer Orthodontics' management manipulating its earnings.
Lancer Orthodontics Stock Summary
Lancer Orthodontics competes with Bionano Genomics, Microbot Medical, STAAR Surgical, and Envista Holdings. Lancer Orthodontics, Inc. designs, manufactures, and markets orthodontic products for orthodontists and dentists worldwide. The company was founded in 1967 and is based in Vista, California. Lancer Orthodontics operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 134 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US5146243036 |
| Business Address | 1493 Poinsettia Building, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.lancerortho.com |
| Phone | 760 744 5585 |
| Currency | USD - US Dollar |
Lancer Orthodontics Key Financial Ratios
Lancer Orthodontics' financial ratios allow both analysts and investors to convert raw data from Lancer Orthodontics' financial statements into concise, actionable information that can be used to evaluate the performance of Lancer Orthodontics over time and compare it to other companies across industries.| Return On Equity | 0.0331 | |||
| Return On Asset | 0.0048 | |||
| Number Of Employees | 134 | |||
| Beta | 0.85 | |||
| Z Score | 1.0 |
Lancer Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lancer Orthodontics's current stock value. Our valuation model uses many indicators to compare Lancer Orthodontics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lancer Orthodontics competition to find correlations between indicators driving Lancer Orthodontics's intrinsic value. More Info.Lancer Orthodontics is rated second overall in return on equity category among its peers. It is rated third overall in return on asset category among its peers reporting about 0.15 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Lancer Orthodontics is roughly 6.90 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Lancer Orthodontics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lancer Orthodontics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Lancer Orthodontics Systematic Risk
Lancer Orthodontics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Lancer Orthodontics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Lancer Orthodontics correlated with the market. If Beta is less than 0 Lancer Orthodontics generally moves in the opposite direction as compared to the market. If Lancer Orthodontics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Lancer Orthodontics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Lancer Orthodontics is generally in the same direction as the market. If Beta > 1 Lancer Orthodontics moves generally in the same direction as, but more than the movement of the benchmark.
Lancer Orthodontics December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Lancer Orthodontics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lancer Orthodontics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lancer Orthodontics based on widely used predictive technical indicators. In general, we focus on analyzing Lancer Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lancer Orthodontics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 66.67 |
Additional Tools for Lancer Pink Sheet Analysis
When running Lancer Orthodontics' price analysis, check to measure Lancer Orthodontics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lancer Orthodontics is operating at the current time. Most of Lancer Orthodontics' value examination focuses on studying past and present price action to predict the probability of Lancer Orthodontics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lancer Orthodontics' price. Additionally, you may evaluate how the addition of Lancer Orthodontics to your portfolios can decrease your overall portfolio volatility.